[IF=3.8]ARL8B regulates lysosomal function and predicts poor prognosis in hepatocellular carcinoma-Scientific Reports-Published: 10 April 2025
发布日期：2025/5/28 17:33:27
作者：Zhaoxi Peng,‡a Yu Cao,‡b Hongji Pu,‡a Cheng Cao,b Wenxin Yang,a Sen Yang,a Yijun Liu,a Peng Qiu,a Xinrui Yang,a Ruihua Wang,a Chaowen Yu,*d Haoqi Liu,*c Kaichuang Ye*a and Xinwu Lu
单位： Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
期刊：Scientific Reports
DOI：org/10.1039/D4QM00963K
影响因子 ：3.8
引用产品：[FSF0001]-Polyethylenimine Linear（PEI）线性化聚乙烯亚胺(MW25000)
单位： Department of Vascular Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
期刊：Scientific Reports
DOI：org/10.1039/D4QM00963K
影响因子 ：3.8
引用产品：[FSF0001]-Polyethylenimine Linear（PEI）线性化聚乙烯亚胺(MW25000)
上一篇：[IF=6.0]Urokinase-loaded Pt quantum dot self-assembled nanoparticles for inflammation elimination and fibrinolytic thrombus therapy-First published 04 Mar 2025
下一篇：[IF=10.2]Dextran-functionalized cerium oxide nanoparticles for treating diabetic wound infections by synergy between antibacterial activity and immune modulation-Available online 10 June 2025
下一篇：[IF=10.2]Dextran-functionalized cerium oxide nanoparticles for treating diabetic wound infections by synergy between antibacterial activity and immune modulation-Available online 10 June 2025
.jpg)
